Use of statins in cancer patients following acute myocardial infarction and its impact on long-term clinical outcomes.

26 August 2022 (16:15 - 16:55)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Doctor Konrad Stepien

Jagiellonian University Medical College, John Paul II Hospital, Krakow (Poland)

5 More presentations in this session

Presentation thumbnail

Impact of high-intensity statin therapy on glycemic control post-acute coronary syndrome using real-world data

Doctor M. Abdelghani (Doha, QA)

Abstract Slides

Presentation thumbnail

The association between long-term statin use and cataract in both primary and secondary prevention of cardiovascular disease - a nationwide, cohort study on 597,605 cataract patients

Doctor A. Halili (Copenhagen, DK)

Abstract Slides

Presentation thumbnail

Statin use and cardiovascular outcomes after myocardial infarction: a population-based case-control study

Doctor V. Kyto (Turku, FI)

Abstract Slides

Presentation thumbnail

Perioperative rosuvastatin therapy increases creatine kinase and the risk of acute kidney injury in patients undergoing cardiac surgery

Doctor R. Wijesurendra (Oxford, GB)

Abstract Slides

Presentation thumbnail

Drucebo effect in statin therapy: more attributable to the patient, the doctor, or the mass media?

Doctor D. Cosmi (Perugia, IT)

Abstract Slides

Access the full session

Session thumbnail

Statin therapy: clinical role and current challenges

The Event

Event poster

ESC Congress 2022

26 August 2022 16:15 CET

You may be interested in

Congress Presentation

Where are we now? Decision-making in LDL-C lowering and CV risk

Webinar

Unmet needs in lipid management: treatment goals and how to achieve them

Congress Presentation

2025 Focused Update of the 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources